Securite - a specialized chemical company focused on innovation and development of novel antimicrobial solutions and delivery methods for the complex challenges facing the spectrum of public health and safety.
Securite technologies was founded in 2009. Initially, the founding principals began operations as a service provider of antimicrobial technologies in the treatment of hospitality, athletic, and academic facilities as an adjunct to their existing business.
Through its introduction and hands on use of various antimicrobial products, Securite became intimately familiar with multiple technologies and identified active chemistries that showed the greatest promise for growth potential and expansion into new, underserved markets.
In order to introduce treatments into markets with high risk environments, new formulations and persistent modifications surrounding these active technologies were needed. The commitment was made to fully embrace and develop these chemistries to their full potential.
From the onset, empirical data mining in uncharted territories, and building an indisputable trove of proven efficacy and safety has been at the core of Securite focus. A continuum of microbiological laboratory testing, field trials, advanced toxicology, and expanded post-treatment substrate studies are in a constant progression.
Early data mining activities and evaluation has given way to more recent university based clinical research studies conducted by highly respected and trusted academic institutions. These clinical studies focus on market trajectories unimagined even a few short years ago.
Securite has grown its core management to include PhD level medical and formulating chemistry positions to guide the company’s ascension into its newest and most challenging market vectors.
“From the onset, empirical data mining in uncharted territories, and building an indisputable trove of proven efficacy and safety has been at the core of Securite focus.”